SG buyout firm CBC said to mull IPO for Chinese drugmaker Everest

Brightly coloured pharmaceutical medication, including antibiotics, paracetamol, Ibuprofen and cold relief tablets, manufactured by a variety of companies sit in this arranged photograph in London, U.K., on Friday, April 27, 2018. Photographer: Chris Ratcliffe/Bloomberg Photo by Bloomberg

CBC Group, a Singapore-based private equity firm, is exploring an initial public offering for its biopharmaceutical company Everest Medicines, according to people familiar with the matter.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.